New HRSA funding is available to providers that administer the COVID-19 vaccine and don’t receive full payment from a health plan
The Health Resources and Services Administration announced a new program to reimburse healthcare providers for administering COVID-19 vaccines to patients whose health plans either do not cover vaccination fees or require cost-sharing.
Denials management: An underrated tool for optimizing value-based revenue
Effective denials management not only supports a strong revenue stream under existing fee-for-service payment models, but also is a key tool for managing the full range of value-based payment contracts.
4 ways to keep ahead of denials amid the pandemic
Revenue cycle leaders share their perspectives on managing denials during the COVID-10 pandemic, including the need to keep up with new codes and evolving payment guidelines.
Healthcare News of Note: Recent CMS regulations are in limbo under the new administration
News of Note for healthcare finance professionals is a roundup of articles from the past weeks, including, the Biden administration ordering a review of recently finalized regulations across government agencies, leaving the fate of several new CMS rules in question.
Telehealth: Moving from stop-gap measures to an integrated care delivery model
With telemedicine on the rise, two senior leaders advise having proper denials prevention and response strategy, along with ideas on motivating physicians to participate in telehealth programs.
Lessons learned from 2020 HFMA MAP Award winners
Learn key takeaways from 15 revenue cycle leaders who shared performance at the HFMA Digital Annual Conference lessons learned around ways to strengthen and sustain revenue cycle.
How to prevent silent denials from eroding a hospital’s margin
Hospitals should take steps to prevent silent denials. Such denials are a common result of inaccuracies introduced as a result of clinical conservatism, which can have an impact on reimbursement before a claim is submitted.
Coding denials: Creating an effective appeal strategy
Distinguishing coding denials from clinical validation denials is an ongoing challenge, and a good place to review processes.
HFMA conference in New Orleans focuses on achieving a consumer-centric revenue cycle
HFMA conference in New Orleans focuses on achieving a consumer-focused revenue cycle.
Prior-authorization cost and time burdens increase for providers, report finds
Provider burdens from health plans’ use of prior authorization continue to mount amid calls to make the process fully automated.